Propranolol for the treatment of periocular capillary hemangiomas

Milet, Ariane; Dhaybi, Rola Al; Superstein, Rosanne; Powell, Julie; Hamel, Patrick; Chevrette, Lyne; Fallaha, Nicole; Dubois, Josée; Codère, François; McCuaig, Catherine; Hatami, Afshin; Ospina, Luis H.

doi:10.1016/j.jaapos.2009.12.025

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diagnosis was based on the typical appearance of the lesion in all cases of superficial periocular IHs, [12][13][14][15][16][17]19 and in one case of orbital lesion, 13 where a right anterior orbitotomy was performed and the appearance of the lesion was typical of a capillary haemangioma. Imaging in the form of computerized tomography or magnetic resonance imaging was performed to diagnose all intraconal masses (11 cases in this review).…”

Section: Patient Demographicsmentioning

confidence: 99%

The use of propranolol in the management of periocular capillary haemangioma—a systematic review

Cornish

Reddy

2011

Eye

View full text Add to dashboard Cite

Capillary haemangioma or infantile haemangioma (IH) is the most common congenital vascular tumour in the periocular region. Several treatment modalities have been documented, with variable degree of success. Propranolol has recently been reported to be an effective and safe alternative. The aim of this systematic review is to examine the evidence base for the use of propranolol administered orally in the management of periocular capillary haemangioma, and use this information to guide future research. A systematic review of literature was carried out by two independent reviewers using the search strategies highlighted below. A total of 100 cases of oral propranolol use in periorbital or orbital capillary haemangiomas have been documented in the literature. Of the 85 cases that had details of previous treatment, it was used as first-line treatment in 50 (58.8%). The commonest dose used was 2 mg/kg/day. Adverse events were documented in one-third of cases; in most cases these were minor. Improvement or complete resolution of the lesions occurred in 96% of cases. Recurrence was noted in one-fifth of cases. Propranolol has shown a lot of promise in the therapy of IH and further research in the form of properly designed randomized trials is certainly warranted. Treatment guidelines based on literature available to date is included in this review.

show abstract